TY  - RPRT
TI  - Targeting CD25-positive lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as single agent or in combination with targeted agents
AU  - Spriano, F.
AU  - Tarantelli, C.
AU  - Cascione, L.
AU  - Gaudio, E.
AU  - Golino, G.
AU  - Scalise, L.
AU  - Zucca, E.
AU  - Stathis, A.
AU  - Van Berkel, P. H.
AU  - Zammarchi, F.
AU  - Bertoni, F.
PY  - 2023
DO  - 10.1101/2023.07.02.547392
UR  - https://www.biorxiv.org/content/10.1101/2023.07.02.547392v1
ID  - 10.1101/2023.07.02.547392
ER  -